Stockscreener 앱 받기
1.63
8.94%
-0.16
전일 마감가:
$1.79
열려 있는:
$1.75
하루 거래량:
129.44K
Relative Volume:
0.11
시가총액:
$19.88M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-18.50%
1개월 성능:
+17.27%
6개월 성능:
-48.25%
1년 성능:
-95.45%
1일 변동 폭
$1.5875
$1.82
1주일 범위
$1.5875
$2.09
52주 변동 폭
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
명칭
Q 32 Bio Inc
전화
781-999-0232
주소
830 WINTER STREET, WALTHAM
QTTB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.63 | 23.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-11 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | Raymond James | Strong Buy |
| 2024-09-11 | 개시 | Wells Fargo | Overweight |
| 2024-06-17 | 개시 | Guggenheim | Buy |
| 2024-05-21 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Oppenheimer | Outperform |
| 2024-04-02 | 개시 | Piper Sandler | Overweight |
| 2023-07-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 재확인 | BTIG Research | Neutral |
| 2022-02-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-02-22 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-12-14 | 재개 | H.C. Wainwright | Buy |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 개시 | Chardan Capital Markets | Buy |
| 2019-11-01 | 개시 | Oppenheimer | Perform |
| 2019-09-10 | 개시 | Robert W. Baird | Outperform |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
모두보기
Q 32 Bio Inc 주식(QTTB)의 최신 뉴스
Can trapped investors hope for a rebound in Q32 Bio Inc.Free Community Verified Stock Suggestions - Newser
How Q32 Bio Inc. stock reacts to Fed policy changesSwing Trade Entry and Exit Point Analysis - Newser
Will Q32 Bio Inc. benefit from rate cutsTop Fast Growth Opportunities - thegnnews.com
Does Q32 Bio Inc. qualify in momentum factor screeningEarly Buy Opportunity with Chart Triggers - Newser
Should you wait for a breakout in Q32 Bio Inc.Daily Stock Watch Summary with Key Insights - Newser
Will Q32 Bio Inc. rebound enough to break evenReal-Time AI Generated Market Forecast - Newser
Q32 Bio Inc. stock outlook for YEARSwing Trade Watchlist with Entry Zones - Newser
Understanding Q32 Bio Inc.’s price movementTrend Reversal Watch with Entry Signals - Newser
What earnings revisions data tells us about Q32 Bio Inc.Free High Yield Stock Screening Results - Newser
Published on: 2025-08-08 22:53:46 - Newser
Can a trend reversal in Q32 Bio Inc. lead to recoveryFree Sector Based Breakout Stock Forecast - Newser
Historical volatility pattern of Q32 Bio Inc. visualizedVolume Based Swing Signal Prediction Map - Newser
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts - TipRanks
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Using portfolio simulators with Q32 Bio Inc. includedWeekly Outlook for Short Term Investors - Newser
Q32 Bio: Q2 Earnings Snapshot - The Washington Post
Q32 Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Inc. SEC 10-Q Report - TradingView
Q32 Bio Secures FDA Fast Track for Alopecia Treatment as Phase 2 Trial Advances with $54.8M Runway - Stock Titan
How to use Fibonacci retracement on Q32 Bio Inc.Price Action Based Buy Zone Forecast - Newser
Long term hold vs stop loss in Q32 Bio Inc.ROI Focused Watchlist with Trade Confidence - Newser
Intrinsic Value of Q32 Bio Inc. Stock: Is It Undervalued or OvervaluedDaily Pick Forecast with Entry Zones - Newser
Q32 Bio Inc expected to post a loss of 98 cents a shareEarnings Preview - TradingView
Resistance Break Could Fuel Q32 Bio Inc. RallyNews Based Entry Opportunity Alerts Detected - metal.it
What analysts say about Q32 Bio Inc. stockAchieve breakthrough gains with smart trades - Jammu Links News
Trend Reversal Possible in Q32 Bio Inc. Charts IndicateDaily Smart Money Movement Monitor Activated - beatles.ru
Does Q32 Bio Inc. stock perform well during market downturnsMaximize your gains with professional insights - Jammu Links News
What are analysts’ price targets for Q32 Bio Inc. in the next 12 monthsCapitalize on market momentum for maximum gains - Jammu Links News
Published on: 2025-08-03 18:05:59 - Jammu Links News
Custom strategy builders for tracking Q32 Bio Inc.Growth Summary Based on Market Positioning - Newser
How strong is Q32 Bio Inc. company’s balance sheetCapitalize on market shifts with expert advice - Jammu Links News
Using data tools to time your Q32 Bio Inc. exitAI Model Forecasting Reversal and Breakout Zones - Newser
Is it the right time to buy Q32 Bio Inc. stockUnmatched market gains - Jammu Links News
Is Q32 Bio Inc. stock overvalued or undervaluedBuild a winning investment strategy today - Jammu Links News
Earnings visualization tools for Q32 Bio Inc.Breakout Screener With Alert Based Timing - Newser
Q 32 Bio Inc (QTTB) 재무 분석
Q 32 Bio Inc (QTTB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):